On the other hand, other groups have proposed different mechanisms of platelet activation in COVID-19 based on the expression of platelet EMMPRIM (CD147) [21], ACE2-independent mechanisms [29,30], and the presence of aberrant glycosylation in antibodies against spike [31]. The gene discussed is BSG; the disease is COVID-19.